Table 3.

Spearman correlations between significant differentially expressed mRNA and clinical features

Gene	Sex		Age		Disease stage		Survival months
	(N = 217)	p-value	(N = 217)	p-value	(N = 214)	p-value	(N = 216)	p-value
RBL1	− 0.013	0.85	− 0.134	0.049	− 0.108	0.11	0.100	0.14
TGFB2	− 0.081	0.23	− 0.089	0.19	0.114	0.09	− 0.122	0.07
BAMBI	− 0.073	0.28	0.055	0.42	0.037	0.59	− 0.107	0.12
BMP7	− 0.080	0.24	− 0.152	0.03	0.085	0.22	− 0.131	0.05
AMH	− 0.058	0.39	0.092	0.18	− 0.006	0.93	0.008	0.91
TGFBR1	− 0.027	0.69	− 0.060	0.38	− 0.011	0.87	0.044	0.52
IFNG	0.084	0.22	0.087	0.20	− 0.089	0.20	0.081	0.24
BMP5	− 0.053	0.44	0.007	0.91	− 0.010	0.88	0.095	0.16
SMAD5	− 0.074	0.28	− 0.052	0.44	0.035	0.61	0.105	0.12
ID3	− 0.073	0.28	0.040	0.56	− 0.027	0.70	0.061	0.37
TGIF2	− 0.049	0.47	− 0.081	0.23	− 0.179	0.01	0.169	0.01
INHBA	− 0.057	0.41	− 0.071	0.30	0.169	0.01	− 0.083	0.23
ACVR1C	0.051	0.46	− 0.087	0.20	− 0.064	0.36	0.075	0.27
BMP4	0.019	0.78	0.004	0.95	0.091	0.19	− 0.174	0.01
BMP2	0.071	0.30	0.224	0.001	− 0.033	0.63	0.086	0.21
ID1	0.025	0.72	0.017	0.81	− 0.142	0.04	0.084	0.22
E2F5	− 0.070	0.31	− 0.191	0.00	0.059	0.39	0.033	0.63
FST	− 0.092	0.18	− 0.020	0.77	− 0.034	0.62	0.143	0.04
AMHR2	0.041	0.55	0.022	0.75	0.103	0.13	− 0.048	0.48
MYC	− 0.085	0.21	− 0.074	0.28	− 0.157	0.02	0.100	0.14
THBS1	− 0.009	0.90	− 0.016	0.82	− 0.017	0.80	0.079	0.25
LEFTY2	0.013	0.85	− 0.035	0.61	0.120	0.08	− 0.108	0.11
GDF7	0.017	0.80	− 0.122	0.07	0.099	0.15	0.024	0.72
CDKN2B	0.136	0.04	− 0.027	0.69	0.197	0.00	− 0.061	0.37
BMP6	0.022	0.75	0.062	0.36	0.148	0.03	− 0.004	0.96
GDF6	− 0.086	0.21	0.072	0.29	0.132	0.05	− 0.042	0.54
INHBB	− 0.175	0.01	0.001	0.99	0.017	0.80	− 0.039	0.57
TGFBR2	− 0.018	0.79	− 0.196	0.004	− 0.032	0.65	0.041	0.55
PITX2	0.122	0.07	− 0.052	0.44	− 0.066	0.34	0.045	0.51
ID4	− 0.048	0.48	− 0.064	0.35	0.025	0.71	− 0.086	0.21
TGIF1	0.065	0.34	0.057	0.41	− 0.068	0.33	0.029	0.68
TFDP1	− 0.050	0.47	0.116	0.09	− 0.129	0.06	− 0.035	0.61
LEFTY1	0.110	0.11	0.011	0.88	− 0.022	0.75	− 0.021	0.75